MBX Foundation Seeks New Executive Director - Manhattan Beach News
3 days ago • Google News
MBX Biosciences, Inc. Common Stock (MBX)
US$ 9.89-3.61%
Price Chart
Key Statistics
Market Cap
$ 676.25M
P/E Ratio
0.00
Revenue (TTM)
$ 0
Volume
138.5K
52W High
$ 27.50
52W Low
$ 4.81
Dividend Yield
0.00%
Beta
0.00
Technicals
50-Day MA
21.806
200-Day MA
21.806
52 Week High
27.5
52 Week Low
4.807
About MBX
MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision peptide therapies for the treatment of endocrine and metabolic disorders.
Employees
43
Headquarters
Carmel, IN
CEO
Mr. Peter Kent Hawryluk MBA
Latest News
Top Gainers
Symbol/Name
LTP
% Chg
Top Losers
Symbol/Name
LTP
% Chg